Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1302
Selected: 0
NCT IDTitle
NCT00268918Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
NCT02119897Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients
NCT00576680RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors
NCT01173679Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL
NCT01078961An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
NCT03846583Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
NCT00165503Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
NCT03319901Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
NCT05825469Development and Testing of Nutritional Algorithms (NACHO)
NCT01273805Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer
NCT06507930The COMPASSION Study
NCT01221753Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT07516405Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
NCT02623972A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
NCT02873975A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency
NCT00622401Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
NCT02969031Improving Communication Between Cancer Patients & Oncologists
NCT03093428Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
NCT00633958A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors
NCT00580333Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
NCT05528263Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
NCT03613532Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
NCT01378598Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer
NCT02207504Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
NCT02865811Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
NCT05292664Venetoclax Basket Trial for High Risk Hematologic Malignancies
NCT06986174A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
NCT05366413Early Interventional Treatment for Cancer Pain
NCT01078974Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia
NCT04434040Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
NCT07390643The DISCOVER Study
NCT00465023Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases
NCT00916669A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
NCT06854003BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
NCT00483262Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma
NCT00819546RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
NCT01024387AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
NCT01340300Exercise and Metformin in Colorectal and Breast Cancer Survivors
NCT05918263Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial
NCT07052695Mosunetuzumab for CLL MRD Clearance
NCT07397611Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
NCT01325506Effectiveness of Open and Robotic Prostatectomy
NCT06786104Video Inspired Discussions About Ethical Outcomes in Pediatrics
NCT03683680Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
NCT01096602Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
NCT00165269Mantle Irradiation for Hodgkin's Disease
NCT05774886Implantable Microdevice for TNBC - Pilot Study
NCT03993210The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids
NCT06040125Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
NCT04425018MARGetuximab Or Trastuzumab (MARGOT)